Intravitreal Bevacizumab for Type 2 Idiopathic Macular Telangiectasia

Carlos Eduardo Veloso,Raul N. G Vianna,David E. Pelayes,Márcio Bittar Nehemy

Intravitreal Bevacizumab for Type 2 Idiopathic Macular Telangiectasia

2013

Carlos Eduardo Veloso
Raul N. G Vianna
David E. Pelayes
Márcio Bittar Nehemy

Background/Aims: The aim of this paper is to report the treatment of type 2 nonproliferative idiopathic macular telangiectasia (IMT) with intravitreal bevacizumab

Keywords:

Ophthalmology
Anatomy
Bevacizumab
Diabetes mellitus
Idiopathic Juxtafoveal Retinal Telangiectasia
Biology
Macular telangiectasia
intravitreal bevacizumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations